106-23-0
CAS 106-23-0
106-23-0 (CAS 106-23-0) is a pharmaceutical compound with 0 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
IUPHAR Ligand-Target Data
Curated ligand-target interaction rows with action, affinity, and literature identifiers.
| Target | Action | Affinity | PubMed |
|---|---|---|---|
| TAS2R43 TAS2R43 |
Antagonist | 4.079999923706055 pIC50 | 27569025 |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is 106-23-0 used for in pharmaceutical contexts?
106-23-0 (CAS 106-23-0) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for 106-23-0?
No adverse-event association or SIDER side-effect rows are rendered for 106-23-0 in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is 106-23-0 also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Citronellal with EU status "restricted".
What clinical phase is 106-23-0 in?
No phase 1-4 clinical development badge is rendered for 106-23-0 because the matched compound identifier rows do not contain a max-phase value.